Supreme Petrochem Q4 FY26: 57% Quarterly PAT Jump, But Is This Specialty Polymer King Quietly Re-Rating or Just Riding a Styrene Mirage?
1. At a Glance – The Plastic Sultan Nobody Talks About
There are companies that scream growth.
And then there are companies that quietly mint cash while investors chase glamorous stories.
Supreme Petrochem Ltd sits oddly in the second bucket.
50% market share in polystyrene and EPS. Debt almost irrelevant. ₹701 crore investible surplus. 21% ROCE. A brand-new ABS plant. Renewable power feeding half the main plant. Yet market gives it a P/E of 45 like it is some confused commodity stock with an identity crisis.
Why?
Because this business has a split personality.
One side is boring commodity chemicals—spread-driven, cyclical, brutal.
The other side is a stealth specialty chemicals story trying to emerge through ABS, compounds, Xmold integration and downstream value-added polymers.
That tension is where the drama sits.
And FY26 was full of drama.
Revenue down 11.4%.
PAT down 16%.
But Q4 PAT explodes 57%.
Margins rebound to 15.95%.
ABS starts, then a proprietary equipment failure shuts it down.
You can’t make this up.
This is a company where management says “we are debt free and funding capex internally,” while also casually planning multi-year expansions in ABS, Haryana and specialty compounds.
One part fortress.
One part experiment.
One part chemical soap opera.
And the funniest part?
Volumes hit all-time highs even while reported revenue shrank because styrene prices fell.
Imagine selling more and reporting less.
Classic commodity comedy.
Question for readers:
Is this a commodity company being mistaken for a specialty company…
or a specialty company still trapped inside commodity valuations?
That may decide the next decade.
2. Introduction – When Plastics Become Philosophy
If Benjamin Graham had covered petrochemicals, he might have loved this.
Because Supreme Petrochem looks simple.
It is not.
This is a spread business disguised as manufacturing.
Raw material: Styrene monomer.
Finished products: Polystyrene. Expandable polystyrene. XPS. Compounds. Now ABS.
Translation:
They buy chemistry. They sell margin.
And margin can behave like a Bollywood villain.
FY21-FY22 margins at 18-21%.
Then normalize to 9-10%.
Now Q4 suddenly back near 16%.
Commodity spreads can make geniuses look stupid and average managers look brilliant.
Which is why this story is fascinating.
Management actually walked much of its earlier talk.
Old concall: ABS as next growth engine.
Reality: 70,000 TPA commissioned.
Talk walked.
Old concall: Value-added mix to cushion volatility.
